Since the early 1990s, colposcopy of the vagina and cervix has been used in
the development of vaginal products in order to detect epithelial changes
that may increase the likelihood of HIV or acquisition of other sexually tr
ansmitted diseases. As part of a continued effort to examine and define the
role of colposcopy in a research setting, the Contraceptive Research and D
evelopment Program (CONRAD) and the International Working Group on Microbic
ides (IWGM), in association with the United Nations Program for AIDS (UNAID
S) sponsored a conference entitled, 'The Use of Colposcopy in Assessing Vag
inal Irritation in Research', held in Washington, DC in January 1999. This
is a report of that conference.
The World Health Organization's colposcopy procedure and nomenclature, publ
ished in 1995, were reviewed and changes were recommended. The revised proc
edure involves colposcopic examination of the external genitalia, naked eye
examination of the cervix, fornices, and vaginal walls, followed by lavage
and colposcopic examination of those areas, and sampling as appropriate fo
r microscopic examination. Revised nomenclature replaces the terms used for
findings with descriptions of what is actually seen. Digital video imaging
and testing for inflammatory markers may be adjuncts to colposcopy and sho
uld be further studied. Other areas requiring additional research include t
he natural history of colposcopic changes, factors other than product use t
hat may affect colposcopic findings, the clinical significance of findings,
and the procedure which best assesses these findings. (C) 2000 Lippincott
Williams & Wilkins.